FDA overdue on guidance as DSCSA deadline looms
Regulatory NewsJoanne S. Eglovitch
ComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchComplianceNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy